SAN FRANCISCO, Jan. 30 (UPI) -- Swiss pharmaceutical giant Roche said it would initiate a tender offer to take over U.S. biotechnology company Genentech.
SOUTH SAN FRANCISCO, Calif., Aug. 14 (UPI) -- Swiss pharmaceutical behemoth Roche will have to dig deeper into its pockets if it wants to own all of Genentech Inc., which rejected its $43.7 billion offer.
BASEL, Switzerland, July 21 (UPI) -- Swiss drugmaker Roche Holding AG has offered $43.7 billion -- $89 a share -- for the U.S. biotech firm Genentech.
BASEL, Switzerland, July 9 (UPI) -- Swiss drug maker Roche and U.S. biotech firm Alnylam Monday announced they have entered a pact in which Roche has licensed Alnylam's RNAi technology.
FOSTER CITY, Calif., Nov. 16 (UPI) -- Switzerland's Roche Holding AG settled a long-running row with Gilead Sciences Inc. over licensing of Tamiflu, seen as a key weapon against a flu pandemic.
ZURICH, Switzerland, Oct. 19 (UPI) -- Sales of Roche Holding AG's Tamiflu influenza vaccine are ballooning as fears of bird flu engulf Europe.
RENZBERG, Germany, July 5 (UPI) -- Swiss pharmaceutical company Roche will invest more than $500 million in two new biotechnology plants in Bavaria, a German daily reported Tuesday.
FOSTER CITY, Calif., June 24 (UPI) -- California's Gilead Sciences Inc. is pulling the license for its anti-flu drug Tamiflu from Swiss pharmaceutical giant Roche Holding AG.
BASEL, Switzerland, Jan. 14 (UPI) -- Roche Holding AG has announced the European Commission's approval of Avastin for patients with metatastic cancer of the colon or rectum.
LEVERKUSEN, Germany, July 19 (UPI) -- Germany's Bayer drug company will buy the over-the-counter business of Switzerland's Roche for $2.96 billion, the Financial Times reported Monday.
